Telomerase activity and hTERT protein expression in meningiomas: An analysis in vivo versus in vitro

Anticancer Research

Volumn 26, Issue 3 B, 2006, Pages 2295-2300

  Maes, Lode ^a   Kalala, J P O ^b   Cornelissen, R ^a   De Ridder, L ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

hTERT; Meningiomas; Telomerase

Indexed keywords

RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADULT; AGED; AGED, 80 AND OVER; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 33745517216     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Blackburn EH: Structure and function of telomeres. Nature 350: 569-573, 1991.
2. Smith S: Recombination: a means to an end in human cells. Nat Genet 26: 388-389, 2000.
3. Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB, Taylor RD, Carlos R, Andrews WH, Wright WE, Shay JW, Harley CB and Morin GB: Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 17: 498-502, 1997.
4. Masutomi K, Kaneko S, Hayashi N, Yamashita T, Shirota Y, Kobayashi K and Murakami S: Telomerase activity reconstituted in vitro with purified human reverse transcriptase and human telomerase RNA component. J Biol Chem 275: 22568-22573, 2000.
5. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S and Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715, 1995.
6. Harle-Bachor C and Boukamp P: Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93: 6476-6481, 1996.
7. Simon M, Park TW, Leuenroth S, Hans VH, Loning T and Schramm J: Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression. J Neurosurg 92: 832-840, 2000.
8. Cabuy E and de Ridder L: Telomerase activity and expression of telomerase reverse transcriptase correlated with cell proliferation in meningiomas and malignant brain tumors in vivo. Virchows Arch 439: 176-184, 2001.
9. Kleihues P and Cavenee WK: WHO Classification of Tumors. Pathology and Genetics. Tumours of the Nervous System. IARCPress, Lyon, France, 2000.
10. Falchetti ML, Larocca LM and Pallini R: Telomerase in brain tumours. Child's Nerv Syst 18: 112-117, 2002.
11. Hiyama E, Gollahan L, Kataoka T, Kuroy K, Yokoyama T, Gazdar AF, Hiyama K, Piatyszek MA and Shay JW: Telomerase activity in human breast tumors. J Natl Cancer Inst 88: 116-122, 1996.
12. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW and Coffey DS: Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 56: 218-222, 1996.
13. Jaaskelainen J, Haltia M and Servo M: Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25: 233-242, 1986.
14. Nakatani K, Yoshimi N, Mori H, Yoshimura SI, Sakai H, Shinoda J and Sakai N: The significant role of telomerase activity in human brain tumors. Cancer 80: 471-476, 1997.
15. Chen HJ, Liang CL, Lu K, Lin JW and Cho CL: Implication of telomerase activity and alternations of telomere length in the histologic characteristics of intracranial meningiomas. Cancer 89: 2092-2098, 2000.
16. Kalala JPO, Maes L, Vandenbroecke C and de Ridder L: The hTERT protein as a marker for malignancy in meningiomas. Oncol Rep 13: 273-277, 2005.
17. Carroll T, Maltby E, Brock I, Royds J, Timperley W and Jellinek D: Meningiomas, dicentric chromosomes, gliomas, and telomerase activity. J Pathol 188: 395-399, 1999.
18. Ducrest AL, Szutorisz H, Lingner J and Nabholz M: Regulation of the human telomerase reverse transcriptase gene. Oncogene 21: 541-552, 2002.
19. Harada K, Kurisu K, Tahara H, Tahara E, Ide T and Tahara E: Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker. J Neurosurg 93: 618-628, 2000.
20. Maes L, Lippens E, Kalala JPO and de Ridder L: The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. Cell Prolif 38: 3-12, 2005.
21. Falchetti ML, Pierconti F, Casalbore P, Maggiano N, Levi A, Larocca LM and Pallini R: Glioblastoma induces vascular endothelial cells to express telomerase in vitro. Cancer Res 62: 3750-3754, 2003.
22. Forsyth NR, Morales CP, Damle S, Boman B, Wright WE, Kopelovich L and Shay JW: Spontaneous immortalization of clinically normal colon-derived fibroblasts from a familial adenomatous polyposis patient. Neoplasia 6: 265-272, 2004.
23. Etheridge KT, Banik SS, Armbruster BN, Zhu Y, Terns RM, Terns MP and Counter CM: The nucleolar localization domain of the catalytic subunit of human telomerase. J Biol Chem 277: 24764-24770, 2002.
24. Smith DL, Soria JC, Morat L, Yang Q, Sabatier L, Liu DD, Nemr RA, Rashid A and Vauthey JN: Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases. Ann Surg Oncol 11: 45-51, 2003.